Health In Tech, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.4% | -1.8% | -2.4% | -10.9% | +10.0% | +63.4% | +16.2% | -8.8% | -11.6% | +16.8% | -8.2% | – | |
| – | +11.3% | +4.0% | -1.5% | +0.5% | +13.0% | +140.2% | +12.9% | +11.4% | +1.0% | +26.1% | -3.0% | – | |
| – | -2.7% | -3.0% | -2.6% | -13.6% | +9.1% | +41.0% | +17.8% | -18.5% | -19.7% | +9.2% | -13.0% | – | |
| – | +34.4% | +12.9% | -7.7% | +2.4% | -11.8% | -15.1% | +8.3% | -59.5% | -9.6% | +331.9% | -4.8% | – | |
| – | -47.4% | +58.5% | -9.1% | -0.2% | +57.0% | +14.0% | +16.3% | -8.6% | -7.9% | +8.7% | +23.5% | – | |
| – | -27.3% | +35.4% | -8.1% | -13.0% | +35.3% | +18.5% | +14.6% | -16.7% | -7.5% | +55.1% | +10.4% | – | |
| – | +180.9% | -77.2% | +60.9% | -18.0% | -172.1% | – | +50.8% | -31.9% | -134.6% | – | – | – | |
| – | – | +14,845.7% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | – | |
| – | +177.9% | -87.0% | +109.3% | +1.4% | -127.2% | – | +21.7% | -28.0% | -173.9% | – | – | – | |
| – | +267.1% | -80.9% | -30.6% | -51.6% | +9.0% | +456.3% | +9.0% | -26.9% | -195.4% | – | – | – | |
| – | +149.1% | -90.0% | +236.2% | +11.3% | -138.3% | – | +26.5% | -28.3% | -166.9% | – | – | – | |
| – | +145.4% | -69.5% | +42.6% | +0.9% | -96.4% | +3,151.1% | +18.1% | -15.6% | -104.0% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.